Literature DB >> 20223440

Allelic variations in angiogenic pathway genes are associated with preeclampsia.

Sindhu K Srinivas1, Alanna C Morrison, Christina M Andrela, Michal A Elovitz.   

Abstract

OBJECTIVE: This study investigates the association of allelic variation in angiogenic pathway genes and preeclampsia. STUDY
DESIGN: Data for cases with preeclampsia and term control subjects were collected prospectively. Maternal DNA was extracted, and 124 tagging single nucleotide polymorphisms in 6 genes (vascular endothelial growth factor A, B, and C; fms-like tyrosine kinase 1 and 4; endoglin) were genotyped. Multivariable logistic regression was used to evaluate the association between tagging single nucleotide polymorphisms and preeclampsia; data were controlled for age. All models were evaluated in black women and white women separately. Haplotype analyses were performed.
RESULTS: We analyzed data from 606 women (489 black women [184 cases] and 117 white women [32 cases]). In black women, the fms-like tyrosine kinase 1 rs12584067 (odds ratio [OR], 1.55; 95% confidence interval [CI], 1.01-2.36; P=.05) and rs7335588 (OR, 1.61; 95% CI, 1.06-2.43; P=.01) and the vascular endothelial growth factor C rs1485766 (OR, 1.56; 95% CI, 1.05-2.30; P=.03) and rs6838834 (OR, 1.60; 95% CI, 1.05-2.45; P=.03) single nucleotide polymorphisms were associated with preeclampsia. In white women, the fms-like tyrosine kinase 1 rs722503 (OR, 2.12; 95% CI, 1.07-4.19; P=.03), fms-like tyrosine kinase 4 rs307826 (OR, 3.06; 95% CI, 1.18-7.91; P=.01), and vascular endothelial growth factor C rs7664413 (OR, 2.04; 95% CI, 0.99-4.17; P=.04) single nucleotide polymorphisms were associated with preeclampsia.
CONCLUSION: Allelic variations in the fms-like tyrosine kinase 1 and vascular endothelial growth factor C genes are associated with preeclampsia in both ethnic groups. Copyright (c) 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223440     DOI: 10.1016/j.ajog.2010.01.040

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  25 in total

Review 1.  Candidate Gene, Genome-Wide Association and Bioinformatic Studies in Pre-eclampsia: a Review.

Authors:  Semone Thakoordeen; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2018-08-29       Impact factor: 5.369

2.  Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.

Authors:  Eleazar Soto; Roberto Romero; Juan Pedro Kusanovic; Giovanna Ogge; Youssef Hussein; Lami Yeo; Sonia S Hassan; Chong Jai Kim; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-25

Review 3.  A systematic review of endoglin gene expression in preeclampsia.

Authors:  Mandy J Bell; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2011-09-15       Impact factor: 2.522

4.  Preeclampsia and the Anti-Angiogenic State.

Authors:  Isha Agarwal; S Ananth Karumanchi
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

5.  VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population.

Authors:  Melissa D Amosco; Van Anthony M Villar; Justin Michael A Naniong; Lara Marie G David-Bustamante; Pedro A Jose; Cynthia P Palmes-Saloma
Journal:  Clin Exp Hypertens       Date:  2016-09-26       Impact factor: 1.749

6.  Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Authors:  Amy E Whitten; Roberto Romero; Steven J Korzeniewski; Adi L Tarca; Alyse G Schwartz; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

7.  Role of VEGF-C gene polymorphisms in susceptibility to hepatocellular carcinoma and its pathological development.

Authors:  Ming-Chang Hsieh; Hui-Ting Hsu; Pei-Ching Hsiao; Shun-Fa Yang; Chao-Bin Yeh; Mauo-Ying Bien; Chien-Huang Lin; Ming-Hsien Chien
Journal:  J Clin Lab Anal       Date:  2014-01-29       Impact factor: 2.352

8.  Clinical factors associated with readmission for postpartum hypertension in women with pregnancy-related hypertension: a nested case control study.

Authors:  A Hirshberg; L D Levine; S K Srinivas
Journal:  J Perinatol       Date:  2016-01-14       Impact factor: 2.521

9.  Osteonecrosis of the jaw risk factors in bisphosphonate-treated patients with metastatic cancer.

Authors:  Catherine Van Poznak; Evan L Reynolds; Cherry L Estilo; Mimi Hu; Bryan Paul Schneider; Daniel L Hertz; Christina Gersch; Jacklyn Thibert; Dafydd Thomas; Mousumi Banerjee; James M Rae; Daniel F Hayes
Journal:  Oral Dis       Date:  2020-12-14       Impact factor: 3.511

10.  Preeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China.

Authors:  Yingying Yang; Isabelle Le Ray; Jing Zhu; Jun Zhang; Jing Hua; Marie Reilly
Journal:  JAMA Netw Open       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.